Zeke Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
AWA
Zeke Capital Advisors's AMGN Position: Q4 2022 in Review
Zeke Capital Advisors reduced its Amgen (AMGN) stake by 21% in Q4 2022, selling an estimated $191K and leaving 2,761 shares worth $725K. The position accounts for 0.05% of the portfolio, ranked #189.
Zeke Capital Advisors first reported a position in AMGN in Q4 2014 and has held it in 20 quarters since. The position peaked at $3.08M in Q3 2018. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.
- Zeke Capital Advisors held 2,761 shares of Amgen worth $725K as of Q4 2022.
- Zeke Capital Advisors sold 714 Amgen shares in Q4 2022, an estimated $191K.
- Amgen made up 0.05% of Zeke Capital Advisors's portfolio in Q4 2022, its #189 holding.
- Zeke Capital Advisors first reported a position in Amgen in Q4 2014 and has held it in 20 quarters since.
- Zeke Capital Advisors's Amgen position peaked at $3.08M in Q3 2018.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.
Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.